Vistagen to Present at TD Cowen 44th Annual Health Care Conference
28 Fevereiro 2024 - 10:30AM
Business Wire
Vistagen (Nasdaq: VTGN), a biopharmaceutical company pioneering
neuroscience to deliver groundbreaking therapies for individuals
affected by psychiatric and neurological disorders, today announced
that company management will present and host one-on-one meetings
at the TD Cowen 44th Annual Health Care Conference in Boston,
Massachusetts, March 4 to 6, 2024.
TD Cowen 44th Annual Health Care Conference
- Shawn Singh, Chief Executive Officer, will present a corporate
overview on Wednesday, March 6, 2024 at 10:30 a.m. Eastern
Time.
A webcast will be accessible through the “Events” page in the
“Investors” section of the Company’s website at www.Vistagen.com.
Investors interested in arranging a one-on-one meeting during the
conference should contact their Cowen representative.
About Vistagen
Vistagen (Nasdaq: VTGN) is a biopharmaceutical company
pioneering neuroscience to deliver groundbreaking therapies for
individuals affected by psychiatric and neurological disorders.
Five of Vistagen’s clinical-stage neuroscience pipeline candidates
belong to a new class of drugs known as pherines, which are
investigational neuroactive nasal sprays with innovative proposed
mechanisms of action that activate chemosensory neurons in the
nasal passages to impact fundamental neural circuitry in the brain
without the need for systemic absorption or binding to receptors in
the brain. Vistagen’s sixth investigational candidate is an oral
prodrug with potential to inhibit, but not block, NMDA receptor
activity. At Vistagen, we are passionate about delivering
differentiated treatments that set new standards of care for people
living with anxiety, depression, and other neurological disorders.
Connect at www.Vistagen.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240228708023/en/
Investors: Mark A. McPartland (650) 577-3606
markmcp@vistagen.com
Media: Caren Scannell (650) 577-3601 cscannell@vistagen.com
VistaGen Therapeutics (NASDAQ:VTGN)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
VistaGen Therapeutics (NASDAQ:VTGN)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024
